Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes (Q39447029)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

A M Namboodiri

1

1 reference

Europe PubMed Central

12 September 2017

J P Pandey

2

1 reference

Europe PubMed Central

12 September 2017

publication date

1 December 2011

1 reference

Europe PubMed Central

12 September 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

12 September 2017

166

1 reference

Europe PubMed Central

12 September 2017

3

1 reference

Europe PubMed Central

12 September 2017

361-365

1 reference

Europe PubMed Central

12 September 2017

Fcgamma receptors as regulators of immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Engineered antibody Fc variants with enhanced effector function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Monoclonal antibodies: versatile platforms for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Toward a genetics of cancer resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

The IgG binding site of human FcgammaRIIIB receptor involves CC' and FG loops of the membrane-proximal domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Expression of human FcgammaRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232384

1 October 2018

Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232384

1 October 2018

Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232384

1 October 2018

The Human Low Affinity Fcγ Receptors IIa, IIb, and III Bind IgG with Fast Kinetics and Distinct Thermodynamic Properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04477.X

21 January 2018

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/22059994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22059994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of whole blood antibody dependent cellular cytotoxicity by heat aggregated human IgG

1 reference

https://pubmed.ncbi.nlm.nih.gov/22059994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2011.04477.X

1 reference

Europe PubMed Central

12 September 2017

0 references

1 reference

Europe PubMed Central

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39447029&oldid=1828588873"